The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
aims to provide a high level of dividend as well as capital appreciation from a diversified portfolio
Find out MoreLondon South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bt
maybe if you had thought a bit more you would have known.
RNS posted on the 11th stated a NAV of 233p.
The share price has been at a discount for many months, but is currently back to what has been the norm most of the time - a premium.
Given today’s NAV of 227.50 I’m not sure where you’re getting that figure?
''its normal small premium ''
currently that would need a share price of about 237p
Potential to move back to its normal small premium if this can be sustained
Looking like a steady (if bumpy) rise back, with good divi happy to hold for now
Not necessarily, dividends are starting to feed through as per RNS today. Expect a small retrace monday given last nights Asia performance but NAV of 234 is getting back to normal. Nasty sell of the six month year end of 2023 but average 201p now so not complaining too much.
Has to retrace now to cover the divi.
Some positive news from HSBC at least:
https://www.cnbc.com/2024/03/14/hsbc-is-very-positive-about-the-future-of-chinas-economy-cfo-says.html
Hi LTI, good to see the nav creeping back up. Recent div most welcome and the buybacks I assume because they also think they’re too cheap!
The SP seems to trail the nav around 10p these days and hopefully in time they’ll narrow the gap from when we always seemed to be 10p over!
Good to see it now over 230p for first time in a while
229p -
not so long ago the share price would have been at about 235p on that nav
Https://markets.ft.com/data/announce/detail?dockey=1323-16358226-300P959R6U6OOTTTP6E7EQ0LL5
......upside on capital. Given geo-political tensions coupled with the recent announcement that BABA has significantly more state ownership than previously disclosed I think HFEL should now be treated closer to a bond proxy, albeit they'll need to work hard to maintain their dividend. I like the stock at this price and will add if it drops below 200. They've clearly been working to reduce their exposure to China but the stocks they've moved into are speculative to say the least.
Agreed on the the lack of confidence that remaining exposure to China via JD and BABA will yield any short term
Mm99
25 Oct 2023 10:29
''180p will get me interested in this one.''
does this qualify you as being shifty?
Pretty standard for most active managed funds, lesson is steer away from them, most always lose money long term. Only ones that make money is the shifty fund managers.
Btw HFEL invest in businesses not an index
Sk1
incorrect
Hfel had a high china exposure years before the peak in which it sold into .
exposure was increased again at the end of 2022 way off of highs. this was then quickly reversed.
Chinal/Hong Kong still make up about a quarter of the portfolio.
India investment made well before the current high index values
Piled into China near the top... Piling into India near a top... Sounds good...
Lost the faith here. Previously posted here i thought China would come back and lift nav later on this year. No longer think that. Sadly lost about £8k after dividends. Good luck to all those still invested but personally no longer see hfeit as a short term capital gain candidate sadly
My problem is a dividend cut would be disastrous for me as it forms a large part of my pension drawdown, if it's cut then the chance of a rise in SP won't offset the drop so I'd have to sell shares at below purchase price so a double whammy. I need the div to at least stay and hope the SP recovers over time, happy to see a reduction in China as I cannot see it recovering any time soon and MK was sure it would??? A good move for him to stand down but lets hope the new direction works (fingers crossed)
But are they going into India as a time when it is peaking? Some believe the Nifty-50 is 20% overvalued. They should have been in there five years ago.
https://www.business-standard.com/finance/personal-finance/nifty-50-20-overvalued-expect-time-correction-in-6-months-kotak-securities-124010200125_1.html
Coming out of China and going into India Indonesia and more in Australia would be good interesting as politically less obnoxious but question the extent. Would be annoying to miss a Chinese rebound -admit bottom fishing hazardous but obviously trading scope in China if not long holds. Always thought these worth 2.97 when will they ever get back there?
Notwithstanding the dividend discussion, where many investors seem aligned, I was pleased to hear the rotation from China to India and Indonesia. This appears to be a good decision supposedly suggested by the new manager. But the idea that they somehow can cleverly time the divesture/investing and trade around the dividends, I don t believe. That's also not sustainable. Again, at the moment the risk to the share price must be heavily in favour of the downside. A modest cut in dividend surely should alleviate at least some of that risk?